ScholarIQanswers from OpenAlex

MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.

PaperCitations, authors & open-access status

MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. have?

ScholarIQcitation count

MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. has 56 citations in the OpenAlex counts ScholarIQ stores.

When was MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. published?

ScholarIQyear

MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. has 2015 year in the ScholarIQ index.

What is the open-access status of MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.?

ScholarIQoa status

MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. has green oa status in the ScholarIQ index.

What is the PMID of MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.?

ScholarIQpmid

The PMID for MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. is on the source record.

What is the OpenAlex record for MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.?

ScholarIQopenalex

The OpenAlex for MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial